规格 | 500μg 1mg |
CAS | N/A |
别名 | N/A |
化学名 | N/A |
分子式 | C33H28D5FN2O4 |
分子量 | 545.7 |
溶解度 | Acetonitrile: soluble,Methanol: soluble |
储存条件 | Store at -20°C |
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
Shipping Condition | Evaluation sample solution : ship with blue ice |
产品描述:
Atorvastatin lactone-d5 is intended for use as an internal standard for the quantification of atorvastatin lactone by GC- or LC-MS. Atorvastatin lactone is an active metabolite of the HMG-CoA reductase inhibitor atorvastatin.1,2 It is formed from atorvastatin by the UDP-glucuronosyltransferase (UGT) isoforms UGT1A3 and UGT1A1 in insect cell-derived supersomes expressing the human enzymes, and hydrolyzes to form atorvastatin in human serum at room temperature.2,3 Atorvastatin lactone inhibits HMG-CoA reductase (IC50 = 0.007 μM for the rat liver enzyme).1 It also inhibits the cytochrome P450 (CYP) isoforms CYP2C9.1 and CYP2C9.3 (IC50s = 16.8 and 5.62 μM, respectively), as well as P-glycoprotein (P-gp; IC50 = 3.1-5.2 μM).4,5
1.Roth, B.D., Blankley, C.J., Chucholowski, A.W., et al.Inhibitors of cholesterol biosynthesis. 3. Tetrahydro-4-hydroxy-6-[2-(1H-pyrrol-1-yl)ethyl]-2H-pyran-2-one inhibitors of HMG-CoA reductase. 2. Effects of introducing substituents at positions three and four of the pyrrole nucleusJ. Med. Chem.34(1)357-366(1990) 2.Schirris, T.J.J., Ritschel, T., Bilos, A., et al.Statin lactonization by uridine 5’-diphospho-glucuronosyltransferases (UGTs)Mol. Pharm.12(11)4048-4055(2015) 3.Jemal, M., Ouyang, Z., Chen, B.C., et al.Quantitation of the acid and lactone forms of atorvastatin and its biotransformation products in human serum by high-performance liquid chromatography with electrospray tandem mass spectrometryRapid Commun Mass Spectrom.13(11)1003-1015(1999) 4.Shiozawa, A., Yamaori, S., Kamijo, S., et al.Effects of acid and lactone forms of statins on S-warfarin 7-hydroxylation catalyzed by human liver microsomes and recombinant CYP2C9 variants (CYP2C9.1 and CYP2C9.3)Drug Metab. Pharmacokinet.36100364(2021) 5.Bogman, K., Peyer, A.-K., T?r?k, M., et al.HMG-CoA reductase inhibitors and P-glycoprotein modulationBr. J. Pharmacol.132(6)1183-1192(2001)
.
特别提醒:
1. 本产品仅供科研使用。请勿用于医药、临床诊断或治疗,食品及化妆品等用途。请勿存放于普通住宅区。
2. 为了您的安全和健康,请穿好实验服并佩戴一次性手套和口罩操作。
联系人:高小姐
手 机:13585831301
Q Q:3004967995
座 机:021-59541103
传 真:021-60443211
地 址:上海嘉定区嘉罗公路1661